KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

KORU Medical Systems Inc.

An announcement from REPRO-MED Systems ( ($KRMD) ) is now available. REPRO‑MED Systems, a medical device company focused on home infusion therapies...

REPRO-MED Shareholders Back Board, Governance and Incentive Plan

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alpha Teknova (TKNO) and REPRO-MED Systems (KRMD) wi...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Record Date	N/A	Declaration	N/A
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KRMD	$4.18	+0.72%	70.78K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KRMD	$4.18	+0.7%	70.78K
3
4
5
6

KRMD

KRMD

Dividend Overview

Get KORU Medical Systems Inc. Data in Excel

Get KORU Medical Systems Inc. Data in Excel